NutriStack
Vitamin D3 and Zoledronic Acid, a synergy.
Vitamin D status strongly predicts both the acute-phase reaction risk (fever, myalgia, flu-like symptoms after infusion) and the risk of post-infusion hypocalcemia. Patients with serum 25(OH)D below 30 ng/mL had a four-fold higher odds of acute-phase reaction in a prospective cohort. Manufacturer and major guidelines require correction of vitamin D deficiency before each zoledronate infusion.
One pair, every claim cited. The two substances, the type, the mechanism, the recommendation, and the primary literature.
Same shape as the other 1,729 pairs in the public database.
From the interaction database
What the row says.
Every entry follows the same shape: what is happening, the mechanism, the recommendation, and the primary literature.
At a glance
- Substances
- Vitamin D3 and Zoledronic Acid
- Pair type
- Synergy
- Evidence (highest tier)
- Strong
- Source citations
- 2 sources
- Stack Score effect
- +2 to your Stack Score (per scored synergy row).
- Scope
- Supplement × Prescription
- Last verified
- May 30, 2026
Synergy · Strong evidence
Synergy
What is happening. Vitamin D status strongly predicts both the acute-phase reaction risk (fever, myalgia, flu-like symptoms after infusion) and the risk of post-infusion hypocalcemia. Patients with serum 25(OH)D below 30 ng/mL had a four-fold higher odds of acute-phase reaction in a prospective cohort. Manufacturer and major guidelines require correction of vitamin D deficiency before each zoledronate infusion.
Mechanism. Vitamin D maintains serum calcium via intestinal absorption and PTH suppression. Zoledronate causes a rapid drop in bone-derived calcium release; if vitamin D is low, the calcium cannot be replaced from the gut and symptomatic hypocalcemia follows. Vitamin D also dampens the gamma-delta T-cell-driven acute phase response.
Recommendation. Have your 25(OH)D checked before any zoledronic acid infusion and correct deficiency (often 50,000 IU loading dose, then 1000-2000 IU/day) to a target above 30 ng/mL. Continue daily vitamin D3 indefinitely while on therapy.
Sources (2)
- Crotti C, Watts NB, De Santis M, et al. Acute Phase Reactions After Zoledronic Acid Infusion: Protective Role of 25-Hydroxyvitamin D and Previous Oral Bisphosphonate Therapy. Endocr Pract. 2018;24(5):405-410. PMID 29498910
- Catalano A, Bellone F, Morabito N, et al. Vitamin D Boosts Alendronate Tail Effect on Bone Mineral Density in Postmenopausal Women with Osteoporosis. Nutrients. 2021;13(6):1878. PMID 34072655
Stack Score
How this pair moves the number.
Effect on the composite score
If both Vitamin D3 and Zoledronic Acid are in the same stack, this pair applies +2 to your Stack Score (per scored synergy row).
The full algorithm, the clamping rules, and four worked stacks are documented at /methodology/stack-score.
Check your full routine
One pair was the worked example. NutriStack runs every pair in your stack at once.
Drop in your supplements and prescriptions and the public database surfaces every interaction, synergy, timing rule, and contraindication, every one linked to its primary source.